{"id":"https://openalex.org/W7223156789","doi":"https://doi.org/10.1016/j.htct.2026.107508","title":"IMMATURE AND EXHAUSTED NK/T-CELL PROFILE PRECEDES MOLECULAR RELAPSE AND PREDICTS TREATMENT-FREE REMISSION FAILURE: DATA FROM THE DES-CML TRIAL","display_name":"IMMATURE AND EXHAUSTED NK/T-CELL PROFILE PRECEDES MOLECULAR RELAPSE AND PREDICTS TREATMENT-FREE REMISSION FAILURE: DATA FROM THE DES-CML TRIAL","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223156789","doi":"https://doi.org/10.1016/j.htct.2026.107508"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107508","doi":"https://doi.org/10.1016/j.htct.2026.107508","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107508","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2026.107508","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065946121","display_name":"Larissa Sarri Binelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larissa Sarri BINELLI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159161803","display_name":"Leonardo Carvalho PALMA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonardo Carvalho PALMA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159177333","display_name":"Camila Ara\u00fajo Bernardino GARCIA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camila Ara\u00fajo Bernardino GARCIA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123816917","display_name":"Allana Guimar\u00e3es de Carvalho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allana Guimar\u00e3es de CARVALHO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078614518","display_name":"Mariana Medeiros","orcid":"https://orcid.org/0000-0002-7087-0146","observed_orcids":["https://orcid.org/0000-0002-7087-0146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariana MEDEIROS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091123504","display_name":"Beatriz Adjafre","orcid":"https://orcid.org/0000-0002-7899-7328","observed_orcids":["https://orcid.org/0000-0002-7899-7328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatriz Lima ADJAFRE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015325983","display_name":"L Marani","orcid":"https://orcid.org/0000-0003-1579-9700","observed_orcids":["https://orcid.org/0000-0003-1579-9700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leticia Olops MARANI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077574929","display_name":"Rafael Lopes Pacca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rafael Lopes PACCA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093353569","display_name":"Isabela Lefol Arruda","orcid":"https://orcid.org/0000-0003-3028-4027","observed_orcids":["https://orcid.org/0000-0003-3028-4027"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabela Catarin ARRUDA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015796272","display_name":"Priscila Santos Scheucher","orcid":"https://orcid.org/0000-0003-3111-8506","observed_orcids":["https://orcid.org/0000-0003-3111-8506"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priscila Santos SCHEUCHER","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159199484","display_name":"Josiane Lilian Santos SCHIAVINATO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josiane Lilian Santos SCHIAVINATO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159191930","display_name":"Fab\u00edola Atti\u00e9 DE CASTRO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fab\u00edola Atti\u00e9 de CASTRO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024947185","display_name":"Robert S. Welner","orcid":"https://orcid.org/0000-0003-2498-9469","observed_orcids":["https://orcid.org/0000-0003-2498-9469"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Samuel WELNER","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109812718","display_name":"Gislaine Oliveira Duarte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gislaine Oliveira DUARTE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071612435","display_name":"Fernanda Salles Seguro","orcid":"https://orcid.org/0000-0001-6637-3588","observed_orcids":["https://orcid.org/0000-0001-6637-3588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernanda Salles SEGURO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005392796","display_name":"Israel Bendit","orcid":"https://orcid.org/0000-0002-4751-1428","observed_orcids":["https://orcid.org/0000-0002-4751-1428","https://orcid.org/0000-0002-9276-8986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Israel BENDIT","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134506093","display_name":"Renato Sampaio Tavares","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renato Sampaio TAVARES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112661790","display_name":"Leandro Lustri Almeida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leandro Lustri ALMEIDA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159203421","display_name":"Vaneuza Araujo Moreira FUNKE","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vaneuza Ara\u00fajo Moreira FUNKE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159170183","display_name":"K\u00e1tia Borgia Barbosa PAGNANO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K\u00e1tia Borgia Barbosa PAGNANO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016064134","display_name":"Carla Maria Boquimpani de Moura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Maria Boquimpani de MOURA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5122284555","display_name":"Lorena Lobo de Figueiredo Pontes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorena L\u00f4bo de Figueiredo PONTES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80238806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107508","last_page":"107508"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-free-remission","display_name":"treatment-free remission","score":0.8029999732971191},{"id":"https://openalex.org/keywords/molecular-relapse","display_name":"molecular relapse","score":0.8009999990463257},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.7250000238418579},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cytotoxic-nk-cells","display_name":"cytotoxic NK cells","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cd57","display_name":"CD57","score":0.6269999742507935},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.878000020980835},{"id":"https://openalex.org/keywords/dnam-1","display_name":"DNAM-1","score":0.9620000123977661},{"id":"https://openalex.org/keywords/nkp46","display_name":"NKp46","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9440000057220459},{"id":"https://openalex.org/keywords/effector-memory-cd8-t-cells","display_name":"CD8+ effector memory T cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/naive-cd8-t-cells","display_name":"naive CD8+ T cells","score":0.9340000152587891},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.6949999928474426},{"id":"https://openalex.org/keywords/immune-markers","display_name":"immunological markers","score":0.6940000057220459},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9458000063896179},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5697000026702881},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5339999794960022},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3889000117778778},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3070000112056732},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.29429998993873596},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.21699999272823334},{"id":"https://openalex.org/C3020493868","wikidata":"https://www.wikidata.org/wiki/Q55631277","display_name":"Real world data","level":2,"score":0.21220000088214874},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20990000665187836},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.20550000667572021}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107508","doi":"https://doi.org/10.1016/j.htct.2026.107508","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107508","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:08594bb71481446283ed8274db6444b6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/08594bb71481446283ed8274db6444b6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107508- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107508","doi":"https://doi.org/10.1016/j.htct.2026.107508","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107508","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403569074","https://openalex.org/W4405041767","https://openalex.org/W4415671046","https://openalex.org/W2632073066","https://openalex.org/W2995267733","https://openalex.org/W2428623638","https://openalex.org/W3097147940","https://openalex.org/W3096475417","https://openalex.org/W4389231329","https://openalex.org/W4387058769"],"abstract_inverted_index":{"In":[0],"Chronic":[1],"Myeloid":[2],"Leukemia":[3],"(CML),":[4],"only":[5],"50%":[6,128],"of":[7,71,170,266,284,311,385,411,434],"patients":[8,97,165,238,277,307,402],"achieving":[9],"deep":[10],"molecular":[11,27,118],"response":[12,119],"(DMR)":[13],"maintain":[14],"long-term":[15],"treatment-free":[16],"remission":[17],"(TFR)":[18],"after":[19],"tyrosine":[20],"kinase":[21],"inhibitor":[22],"(TKI)":[23],"discontinuation.":[24],"Biomarkers":[25],"predicting":[26],"relapse":[28],"remain":[29],"undefined.":[30],"We":[31],"hypothesized":[32],"that":[33,439],"distinct":[34,106],"antitumoral":[35],"immune":[36,157,242,427,451,480],"signatures":[37],"mediated":[38],"by":[39,101,250],"Natural":[40],"Killer":[41],"(NK)":[42],"and":[43,50,74,94,140,155,184,219,229,259,269,295,316,321,325,353,368,389,407,413,449,456,459,469,487],"T":[44,206,214,231,273,327,336,458],"cells":[45,173,207,215,232,274,328,337],"drive":[46],"TFR":[47,136,141,150,164,380,406,440],"outcomes.":[48],"NK":[49,172,179,225,253,313,324,460],"T-cell":[51],"immunophenotypes":[52],"were":[53,98,344,359],"correlated":[54],"with":[55,281],"BCR::ABL1":[56,483],"kinetics":[57],"in":[58],"a":[59,65,152,240,421,472],"cohort":[60],"from":[61,90,275],"the":[62,78,383,426,444,488],"DES-CML":[63],"study,":[64],"multicenter,":[66],"prospective,":[67],"phase":[68],"2":[69],"trial":[70],"TKI":[72,492],"de-escalation":[73,493],"discontinuation":[75],"conducted":[76],"within":[77],"Brazilian":[79],"public":[80],"healthcare":[81],"system":[82,428],"(SUS)":[83],"across":[84],"seven":[85],"centers.":[86],"Peripheral":[87],"blood":[88],"samples":[89],"20":[91],"healthy":[92],"controls":[93],"118":[95],"CML":[96],"sequentially":[99],"analyzed":[100],"multiparametric":[102],"flow":[103],"cytometry":[104],"at":[105],"timepoints:":[107],"diagnosis":[108],"(DX":[109],"=":[110,115,121,126,133,138,144,176,182,189,193,197,209,227,234,288,293,300],"15),":[111],"Imatinib":[112],"failure":[113,473],"(F":[114],"13),":[116],"major":[117],"(MMR":[120],"10),":[122],"full-dose":[123,246],"DMR":[124,131],"(DMR100":[125],"30),":[127,134],"de-escalated":[129],"dose":[130,303],"(DMR50":[132],"sustained":[135,450],"(n":[137],"31),":[139],"loss":[142],"(TFRL":[143],"9).":[145],"Patients":[146],"who":[147,162],"successfully":[148],"maintained":[149],"exhibited":[151],"highly":[153],"functional":[154],"mature":[156,178],"phenotype":[158],"compared":[159],"to":[160,400,404,474,499],"those":[161],"relapsed.":[163],"displayed":[166,239],"significantly":[167],"higher":[168],"frequencies":[169,283],"cytotoxic":[171,261],"(CD56dim,":[174],"p":[175,181,188,192,196],"0.001),":[177],"(CD57\u207a,":[180],"0.033),":[183],"activating":[185,386],"receptors":[186],"(NKG2D,":[187,387],"0.043;":[190],"DNAM-1,":[191,268],"0.0002;":[194],"NKp46,":[195],"0.033).":[198],"They":[199],"also":[200],"showed":[201],"increased":[202,333],"CD8\u207a":[203,212,230,272,326,335],"effector":[204,290,297],"memory":[205,286,291],"(p":[208,216,226,233,287,292,299,329,338],"0.0011),":[210,294],"lower":[211,264,282],"na\u00efve":[213,334],"<":[217,330,339],"0.0001),":[218],"decreased":[220],"PD-1":[221],"expression":[222,265,384],"on":[223,323,372,443],"both":[224],"0.0052)":[228],"0.046).":[235],"Conversely,":[236],"TFRL":[237,276,306],"pre-existing":[241],"deficit":[243],"even":[244],"during":[245,491],"therapy":[247],"(DMR100),":[248],"characterized":[249],"reduced":[251],"total":[252],"cells,":[254],"CD56dim":[255],"NKs,":[256],"CD56\u207aCD57\u207a":[257],"NK,":[258],"CD11b\u207aCD27\u207b":[260],"subsets,":[262],"alongside":[263,332],"NKG2D,":[267],"NKp46.":[270],"Furthermore,":[271],"presented":[278],"early":[279,432],"impairment":[280],"central":[285],"0.0002),":[289],"terminal":[296],"subsets":[298,314],"0.002).":[301],"During":[302],"reduction":[304],"(DMR50),":[305],"demonstrated":[308,396],"an":[309,377,431],"expansion":[310],"immature/dysfunctional":[312],"(CD11b\u207bCD27\u207a)":[315],"upregulated":[317],"inhibitory":[318,390],"checkpoints":[319],"(TIGIT":[320],"PD-1)":[322,392],"0.05),":[331],"0.0001).":[340],"No":[341,356],"significant":[342,357],"differences":[343,358],"observed":[345,360],"for":[346,361],"KIR2DL1,":[347,362],"NKG2A,":[348,363],"or":[349,364],"overall":[350,365],"CD3,":[351,366],"CD4,":[352,367],"CD8":[354,369],"frequencies.":[355,370],"Based":[371],"these":[373],"findings,":[374],"we":[375],"developed":[376],"immunological":[378],"Predictive":[379],"Score":[381],"integrating":[382],"DNAM-1)":[388],"(TIGIT,":[391],"markers.":[393],"This":[394],"score":[395,490],"robust":[397],"discriminatory":[398],"capacity":[399],"identify":[401],"likely":[403],"sustain":[405],"was":[408],"statistically":[409],"independent":[410],"Sokal":[412],"ELTS":[414],"clinical":[415],"risk":[416],"scores.":[417],"Our":[418],"findings":[419],"highlight":[420],"novel":[422],"prognostic":[423],"axis":[424],"where":[425],"acts":[429],"as":[430,495],"sensor":[433],"residual":[435,476],"leukemia":[436],"dynamics,":[437],"demonstrating":[438],"maintenance":[441],"depends":[442],"balance":[445],"between":[446],"pharmacological":[447],"suppression":[448],"surveillance.":[452],"Specifically,":[453],"mature,":[454],"activated,":[455],"memory-enriched":[457],"cell":[461],"profiles":[462],"predict":[463],"successful":[464],"TFR,":[465],"whereas":[466],"cellular":[467],"immaturity":[468],"exhaustion":[470],"signal":[471],"control":[475],"disease.":[477],"Because":[478],"this":[479],"dysregulation":[481],"precedes":[482],"elevation,":[484],"longitudinal":[485],"monitoring":[486],"DMR100":[489],"emerge":[494],"powerful,":[496],"complementary":[497],"tools":[498],"guide":[500],"safer,":[501],"individualized":[502],"treatment":[503],"cessation.":[504]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}